CHICAGO TRUST Co NA Purchases 3,791 Shares of Danaher Corporation $DHR

CHICAGO TRUST Co NA grew its position in shares of Danaher Corporation (NYSE:DHR) by 55.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 10,624 shares of the conglomerate’s stock after acquiring an additional 3,791 shares during the period. CHICAGO TRUST Co NA’s holdings in Danaher were worth $2,014,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of the stock. JPL Wealth Management LLC bought a new stake in shares of Danaher during the third quarter valued at approximately $25,000. Elevated Capital Advisors LLC purchased a new position in shares of Danaher during the fourth quarter valued at approximately $26,000. WFA of San Diego LLC bought a new stake in shares of Danaher in the 2nd quarter worth approximately $26,000. Hilton Head Capital Partners LLC bought a new stake in Danaher in the fourth quarter worth $27,000. Finally, Clal Insurance Enterprises Holdings Ltd grew its position in Danaher by 71.6% during the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after purchasing an additional 53 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Trading Up 1.7%

NYSE DHR opened at $193.81 on Thursday. The stock has a market cap of $137.17 billion, a PE ratio of 37.49, a PEG ratio of 2.43 and a beta of 0.79. The company’s 50-day moving average price is $178.68 and its 200-day moving average price is $200.76. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating the consensus estimate of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. During the same quarter in the previous year, the firm posted $1.88 earnings per share. The company’s revenue was up 3.7% on a year-over-year basis. Equities research analysts forecast that Danaher Corporation will post 8.44 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio is presently 30.95%.

Analyst Upgrades and Downgrades

Several analysts have commented on DHR shares. HSBC cut their target price on Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research note on Wednesday, June 3rd. Weiss Ratings downgraded shares of Danaher from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday. Citigroup initiated coverage on shares of Danaher in a report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 target price for the company. Wall Street Zen lowered Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, April 25th. Finally, TD Cowen decreased their price target on shares of Danaher from $245.00 to $240.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and a consensus target price of $233.61.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.